Skip to content
Research Article Open access CC BY 3.0

Mathematical Model of Colorectal Cancer with Monoclonal Antibody Treatments

L.G. dePillis, H. Savage, A. E. Radunskaya

Journal of Advances in Medicine and Medical Research · pp. 3101–3131 · Published 14 Mar 2014

10.9734/BJMMR/2014/8393

Abstract

We present a new mathematical model of colorectal cancer growth and its response to monoclonalantibody (mAb) therapy. Although promising, most mAb drugs are still in trial phases, and the possible variations in the dosing schedules of those currently approved for use have not yet been thoroughly explored. To investigate the effectiveness of current mAb treatment schedules, and to test hypothetical treatment strategies, we have created a system of nonlinear ordinary differential equations (ODEs) to model colorectal cancer growth and treatment. The model includes tumor cells, elements of the host’s immune response, and treatments. Model treatments include the chemotherapy agent irinotecan and one of two monoclonal antibodies - cetuximab, which is FDAapproved for colorectal cancer, and panitumumab, which is still being evaluated in clinical trials. The model incorporates patient-specific parameters to account for individual variations in immune system strength and in medication efficacy against the tumor. We have simulated outcomes for groups of virtual patients on treatment protocols for which clinical trial data are available, using a range of biologically reasonable patient-specific parameter values. Our results closely match clinical trial results for these protocols. We also simulated experimental dosing schedules, and have found new schedules which, in our simulations, reduce tumor size more effectively than current treatment schedules. Additionally, we examined the system’s equilibria and sensitivity to parameter values. In the absence of treatment, tumor evolution is most affected by the intrinsic tumor growth rate and carrying capacity. When treatment is introduced, tumor growth is most affected by drugspecific PK/PD parameters.

Colorectal cancer Mathematical model Monoclonal antibody Immunotherapy Mixed chemo-immunotherapy Simulated cohort study In silico tumor growth.

Cited by 31

Translational approaches to treating dynamical diseases through in silico clinical trials

Sofia Alfonso, Adrianne L. Jenner, Morgan Craig · Chaos: An Interdisciplinary Journal of Nonlinear Science · 2020

Modeling Tumor–Immune Dynamics

Lisette G. de Pillis, Ami E. Radunskaya · Springer Proceedings in Mathematics & Statistics · 2014

Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics

Tracy L. Stepien, Eric J. Kostelich, Yang Kuang · SIAM Review · 2020

Parameter estimation and sensitivity analysis for a model of tumor–immune interaction in the presence of immunotherapy and chemotherapy

Hesham A. Elkaranshawy, Ahmed M. Makhlouf · Journal of the Egyptian Mathematical Society · 2022

Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer

Aparajita Budithi, Sumeyye Su, Arkadz Kirshtein · Cancers · 2021

Mathematical Modelling for the Role of CD4+T Cells in Tumor-Immune Interactions

Ahmed M. Makhlouf, Lamiaa El-Shennawy, Hesham A. Elkaranshawy · Computational and Mathematical Methods in Medicine · 2020

Showing 20 of 31 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

31

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.